Politiparty
Politiparty

118th Congress Crime and Law Enforcement

S. 993: Combating Illicit Xylazine Act

Introduced

  1. Introduced (completed)Mar 28, 2023
  2. Passed Senate (not reached)
  3. Passed House (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in Senate, Mar 28, 2023

This bill criminalizes the illicit use of xylazine. (Xylazine, also known as Tranq, is a sedative that is approved for use in animals. The Drug Enforcement Administration (DEA) has reported an increase in the trafficking of fentanyl mixed with xylazine.)

Specifically, the bill establishes criminal penalties for manufacturing, distributing, or dispensing, or possessing with intent to manufacture, distribute, or dispense, xylazine for illicit use (i.e., for use in humans) in accordance with the penalties for schedule III substances (up to 10 years imprisonment or, if death or serious bodily injury occurs, up to 15 years imprisonment, as well as criminal fines).

In addition, the DEA must coordinate with the Food and Drug Administration to report on the prevalence of the illicit use of xylazine, including associated supply chains. The bill also declares the illicit use of xylazine as an emerging drug threat.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

30

Bipartisan support.

Who scored on this bill

12 points earned
  1. 1Catherine Cortez Masto D-NV SponsorDrew cross-party cosponsors, introduced, reached a cosponsor milestone3 events+12
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Catherine Cortez Masto

History

  1. Mar 28, 2023Introduced in the Senate by Catherine Cortez Masto.
Show the full action history (3 actions)
  1. Jan 11, 2024Committee on Banking, Housing, and Urban Affairs. Hearings held.
  2. Mar 28, 2023Introduced in Senate
  3. Mar 28, 2023Read twice and referred to the Committee on the Judiciary.